|
1.
|
|
19 p, 837.6 KB |
Malignant bone tumors (other than Ewing's) : clinical practice guidelines for diagnosis, treatment and follow-up by Spanish Group for Research on Sarcomas (GEIS)
/
Redondo, Andrés (Hospital Universitario La Paz (Madrid)) ;
Bagué Rosell, Sílvia (Institut d'Investigació Biomèdica Sant Pau) ;
Bernabeu, Daniel (Hospital Universitario La Paz (Madrid)) ;
Ortiz-Cruz, Eduardo (Hospital Universitario La Paz (Madrid)) ;
Valverde, Claudia (Hospital Universitari Vall d'Hebron) ;
Alvarez, Rosa (Hospital General Universitario Gregorio Marañón) ;
Martínez-Trufero, Javier (Hospital Universitario Miguel Servet (Saragossa)) ;
Lopez-Martin, Jose A. (Hospital 12 de Octubre (Madrid)) ;
Correa, Raquel (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ;
Cruz, Josefina (Hospital Universitario de Canarias (La Laguna)) ;
López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Santos, Aurelio (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
García del Muro, Xavier (Institut Catalá d'Oncologia Hospitalet) ;
Martin-Broto, Javier (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Universitat Autònoma de Barcelona
Primary malignant bone tumors are uncommon and heterogeneous malignancies. This document is a guideline developed by the Spanish Group for Research on Sarcoma with the participation of different specialists involved in the diagnosis and treatment of bone sarcomas. [...]
2017 -  10.1007/s00280-017-3436-0
Cancer Chemotherapy and Pharmacology, Vol. 80 Núm. 6 (january 2017) , p. 1113-1131
|
|
|
2.
|
|
8 p, 535.7 KB |
Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib
/
Joensuu, Heikki (Helsinki University Hospital) ;
Blay, Jean-Yves (University Claude Bernard Lyon I) ;
Comandone, Alessandro (Gradenigo Hospital) ;
Martin-Broto, Javier (Hosp o Virgen del Rocío (Sevilla, Andalusia)) ;
Fumagalli, Elena (Fondazione IRCCS Istituto Nazionale Dei Tumori) ;
Grignani, Giovanni (Candiolo Cancer Institute. FPO - IRCCS) ;
Del Muro, Xavier Garcia (Hospital Universitari de Bellvitge) ;
Adenis, Antoine (Centre Oscar Lambret) ;
Valverde, Claudia (Hospital Universitari Vall d'Hebron) ;
López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Bouche, Olivier (University Hospital Robert Debre) ;
Italiano, Antoine (Comprehensive Cancer Centre. 2Institut Bergonie) ;
Bauer, Sebastian (University of Duisburg- Essen) ;
Barone, Carlo (University Hospital A. Gemelli) ;
Weiss, Claudia (Novartis Pharma GmbH) ;
Crippa, Stefania (Novartis Farma) ;
Camozzi, Maura (Novartis Farma) ;
Castellana, Ramon (Novartis Farmaceutica SA) ;
Le Cesne, Axel (Gustave Roussy) ;
Universitat Autònoma de Barcelona
This multicentre phase II trial (DOVIGIST) evaluated the antitumour activity of dovitinib as second-line treatment of patients with gastrointestinal stromal tumour (GIST) refractory to imatinib or who do not tolerate imatinib. [...]
2017 - 10.1038/bjc.2017.290
British Journal of Cancer, Vol. 117 Núm. 9 (2017) , p. 1278-1285
|
|
|
3.
|
|
9 p, 1.5 MB |
Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS) : Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups
/
Gronchi, Alessandro (Fondazione IRCCS Istituto Nazionale dei Tumori) ;
Hindi, Nadia (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Cruz, Josefina (University Hospital Canarias) ;
Blay, Jean-Yves (Center Leon Berard (Lyon)) ;
López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Italiano, Antoine (Institute Bergonie - Bourdeaux) ;
Alvarez, Rosa (Hospital General Universitario Gregorio Marañón) ;
Gutierrez, Antonio (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Rincón, Inmaculada (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Sangalli, Claudia (Fondazione IRCCS Istituto Nazionale dei Tumori) ;
Pérez Aguiar, José Luis (Hospital Universitario Canarias) ;
Romero, Jesús (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Morosi, Carlo (Fondazione IRCCS Istituto Nazionale dei Tumori) ;
Sunyach, Marie Pierre (Center Leon Berard) ;
Sanfilippo, Roberta (Fondazione IRCCS Istituto Nazionale dei Tumori) ;
Romagosa, Cleofe (Hospital Universitari Vall d'Hebron) ;
Ranchere-Vince, Dominique (Center Leon Berard) ;
Dei Tos, Angelo (University of Padova) ;
Casali, Paolo G. (University of Milan) ;
Martin-Broto, Javier (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Universitat Autònoma de Barcelona
Myxoid liposarcoma (ML) exhibits a special sensitivity to trabectedin (T) and radiation therapy (RT). Preclinical data suggest a synergistic effect. We aimed to study safety, feasibility and activity of the administration of pre-operative concurrent T and RT in patients affected by localized resectable ML. [...]
2019 - 10.1016/j.eclinm.2019.03.007
EClinicalMedicine, Vol. 9 (march 2019) , p. 35-43
|
|
|
4.
|
|
11 p, 765.0 KB |
A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors
/
Martin-Broto, Javier (Universidad Autónoma de Madrid) ;
Redondo, Andres (Hospital Universitario La Paz (Madrid)) ;
Moura, David S. (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
Valverde, Claudia (Vall d'Hebron Institut d'Oncologia) ;
Morales, Jose Manuel (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Martínez-Trufero, Javier (Hospital Universitario Miguel Servet. Servicio de Oncología Médica) ;
Gutierrez, Antonio (Hospital Universitario Son Espases. Servicio de Hematología) ;
Díaz-Beveridge, Roberto (Hospital Universitari i Politècnic La Fe (València)) ;
Luna, Pablo (Hospital Universitario Son Espases. Servicio de Oncología Médica) ;
Martinez-Marin, Virginia (Hospital Universitario La Paz (Madrid)) ;
Marcilla, David (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Arribas, Ivan (Universitat de València) ;
Ledesma, Patricio (Sofpromed Investigacion Clinica SLU) ;
Lopez-Martin, Jose A. (Hospital Universitario 12 de Octubre (Madrid)) ;
Di Lernia, Davide (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
Zamora, Jorge (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
Hindi, Nadia (Universidad Autónoma de Madrid)
Desmoid fibromatosis (DF) are mesenchymal neoplasms, with potential aggressive course and relevant clinical impact. New systemic therapy modalities are needed in this symptomatic/progressive population. [...]
2022 - 10.1038/s41467-022-33975-6
Nature communications, Vol. 13 Núm. 1 (december 2022) , p. 6278
|
|
|
5.
|
|
12 p, 682.4 KB |
Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with Pazopanib
/
Hidalgo-Ríos, Samuel (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Carrillo García, Jaime (Hospital Universitario General de Villalba. Servicio de Oncología Médica) ;
Moura, David S. (Hospital Universitario General de Villalba. Servicio de Oncología Médica) ;
Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Redondo, Andrés (Hospital Universitario La Paz. Servicio de Oncología Médica. Instituto de Investigación en Salud (IdiPAZ)) ;
Italiano, Antoine (Institut Bergonié. Department of Oncology) ;
Gutiérrez, Antonio (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Grignani, Giovanni (Candiolo Cancer Institute. FPO - IRCCS) ;
Hindi, Nadia (Hospital Universitario Fundación Jiménez Díaz. Servicio de Oncología Médica) ;
López-Guerrero, J.A (Laboratory of Molecular Biology. Fundación Instituto Valenciano de Oncología) ;
Garcia del Muro, Xavier (Institut d'Investigació Biomèdica de Bellvitge) ;
Martínez-Trufero, Javier (Hospital Universitario Miguel Servet. Servicio de Oncología Médica) ;
Palmerini, Emanuela (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Sebio, Ana (Institut d'Investigació Biomèdica Sant Pau) ;
Bernabeu, Daniel (Hospital Universitario La Paz. Sección de Radiología musculoesquelética) ;
Le Cesne, Axel (Gustave Roussy Cancer Campus. Department of Medical Oncology) ;
Casali, Paolo Giovanni (Fondazione IRCCS Istituto Nazionale dei Tumori. Adult Mesenchymal and Rare Tumor Unit. Department of Cancer Medicine) ;
Blay, Jean-Yves (Department of Medical Oncology. Centre Léon Bérard. Université Claude Bernard Lyon) ;
Cruz-Jurado, Josefina (Hospital Universitario de Canarias. Servicio de Oncología Médica) ;
Martín-Broto, Javier (Hospital Universitario Fundación Jiménez Díaz. Servicio de Oncología Médica)
Pazopanib was assessed prospectively in the GEIS-32 phase II study (NCT02066285) on advanced solitary fibrous tumour (SFT), resulting in a longer progression-free survival (PFS) and overall survival (OS) compared with historical controls treated with chemotherapy. [...]
2022 - 10.3390/cancers14174186
Cancers, Vol. 14 Núm. 17 (september 2022) , p. 4186
|
|
|
6.
|
|
10 p, 1.2 MB |
SELNET clinical practice guidelines for soft tissue sarcoma and GIST
/
Blay, Jean-Yves (Léon Bérard Center (Lyon)) ;
Hindi, Nadia (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
Bollard, Julien (Léon Bérard Center (Lyon)) ;
Aguiar Júnior, Samuel (A.C.Camargo Cancer Center (Brasil)) ;
Ángel, Martín Osvaldo (Instituto Alexander Fleming (Buenos Aires)) ;
Araya, Beatriz (Hospital Dr. R. A. Calderón Guardia (San José)) ;
Badilla-González, Ronald (Hospital Dr. Rafael Ángel Calderón Guardia (San José)) ;
Bernabeu, Daniel (Hospital Universitario La Paz (Madrid)) ;
Campos, Fernando (A.C.Camargo Cancer Center (Brasil)) ;
Caro-Sánchez, C.H.S. (Instituto Nacional de Cancerología (Tlalpan)) ;
Carvajal, B. (Fundación GIST México (Mexico)) ;
Carvajal Montoya, A. (Hospital Dr. Rafael Ángel Calderón Guardia (San José)) ;
Casavilca-Zambrano, Sandro (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Castro-Oliden, Victor (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Chacón, Matias (Instituto Alexander Fleming (Buenos Aires)) ;
Clara, Miguel (Instituto Nacional de Cancerología (Tlaplan)) ;
Collini, Paola (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Correa Genoroso, Raquel (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ;
Costa, Felipe D. (A.C.Camargo Cancer Center (Brasil)) ;
Cuellar, M. (Fundación GIST México (Mexico)) ;
Dei Tos, Angelo (Treviso General Hospital Treviso (Padua)) ;
Dominguez Malagón, Hugo Ricardo (Instituto Nacional de Cancerología (Tlalpan)) ;
Donati, Davide Maria (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Dufresne, Armelle (Léon Bérard Center (Lyon)) ;
Eriksson, Mikael (Skane University Hospital (Lund)) ;
Farias-Loza, M. (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Fernandez, Piga (Fundación GIST (Xile)) ;
Frezza, Anna Maria (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Frisoni, Tommaso (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Garcia-Ortega, Dorian Yarih (Instituto Nacional de Cancerología (Tlalpan)) ;
Gelderblom, Hans J (Leiden University Medical Center (Leiden)) ;
Gouin, François (Léon Bérard Center (Lyon)) ;
Gómez-Mateo, María Carmen (Hospital Universitario Miguel Servet (Saragossa)) ;
Gronchi, Alessandro (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Haro-Varas, Juan (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Huanca, Lourdes (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Jimenez, Natalia (Hospital Dr. Rafael Ángel Calderón Guardia (San José)) ;
Karanian, Marie (Léon Bérard Center (Lyon)) ;
Kasper, Bernd (University of Heidelberg (Mannheim)) ;
Lopes David, B.B. (Fondazione IRCCS Istituto Nazionale dei Tumori) ;
López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Lutter, Guido (Instituto Alexander Fleming (Buenos Aires)) ;
Martinez-Said, Héctor (Hospital Medica Sur (Mexico)) ;
Martinez-Tlahuel, Jorge Luis (Instituto Nacional de Cancerología (Tlalpan)) ;
Mello, Celso A. (A.C.Camargo Cancer Center (Brasil)) ;
Morales Pérez, José Manuel (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Moura, David S. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Nascimento, Antônio Geraldo (A.C.Camargo Cancer Center (Brasil)) ;
Ortiz-Cruz, Eduardo J. (Hospital Universitario La Paz (Madrid)) ;
Palmerini, Emanuela (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Patel, Shreyaskumar (University of Texas MD Anderson Cancer Center (Houston)) ;
Pfluger, Yanina (Instituto Alexander Fleming (Buenos Aires)) ;
Provenzano, Salvatore (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Righi, Alberto (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Rodriguez, Andrés (Instituto Alexander Fleming (Buenos Aires)) ;
Salas, Rodrigo (Fundación GIST México (Mexico)) ;
Santos, Telma G. (A.C.Camargo Cancer Center (Brasil)) ;
Scotlandi, Katia (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Soulé, Tomás (Instituto Alexander Fleming (Buenos Aires)) ;
Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Valverde, Claudía María (Hospital Universitari Vall d'Hebron) ;
Waisberg, Federico Daniel (Instituto Alexander Fleming (Buenos Aires)) ;
Zamora Estrada, Esteban (Hospital Dr. Rafael Ángel Calderón Guardia (San José)) ;
Martín-Broto, Javier (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)
2022 - 10.1016/j.ctrv.2021.102312
Cancer Treatment Reviews, Vol. 102 (january 2022) , p. 102312
|
|
|
7.
|
|
10 p, 1.4 MB |
SELNET clinical practice guidelines for bone sarcoma
/
Blay, Jean-Yves (Léon Bérard Center (Lyon)) ;
Palmerini, Emanuela (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Bollard, Julien (Léon Bérard Center) ;
Aguiar Júnior, Samuel (A.C.Camargo Cancer Center) ;
Ángel, Martín Osvaldo (Instituto Alexander Fleming (Buenos Aires)) ;
Araya, Beatriz (Hospital Dr. R. A. Calderón Guardia (San José)) ;
Badilla-González, Ronald (Hospital Dr. R. A. Calderón Guardia (San José)) ;
Bernabeu, Daniel (Hospital Universitario La Paz (Madrid)) ;
Campos, Fernando (A.C.Camargo Cancer Center (Brasil)) ;
CHS, Caro Sánchez (Instituto Nacional de Cancerologia (Tlalpan)) ;
Carvajal Montoya, A. (Hospital Dr. R. A. Calderón Guardia (San José)) ;
Casavilca-Zambrano, Sandro (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Castro-Oliden, Victor (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Chacón, Matias (Instituto Alexander Fleming (Buenos Aires)) ;
Clara-Altamirano, Miguel Ángel (Instituto Nacional de Cancerologia (Tlalpan)) ;
Collini, Paola (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Correa Genoroso, Raquel (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ;
Costa, Felipe D. (A.C.Camargo Cancer Center (Brasil)) ;
Cuellar, M. (Instituto Nacional de Cancerologia (Tlalpan)) ;
Dei Tos, Angelo (Treviso General Hospital Treviso (Padua)) ;
Domínguez Malagón, Hugo Ricardo (Instituto Nacional de Cancerología (Tlalpan)) ;
Donati, Davide Maria (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Dufresne, Armelle (Léon Bérard Center (Lyon)) ;
Eriksson, Mikael (Skane University Hospital (Lund)) ;
Farias-Loza, M. (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Frezza, Anna Maria (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Frisoni, Tommaso (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Garcia-Ortega, Dorian Yarih (Instituto Nacional de Cancerología (Tlalpan)) ;
Gelderblom, Hans J (Leiden University Medical Center (Leiden)) ;
Gouin, François (Léon Bérard Center (Lyon)) ;
Gómez-Mateo, María Carmen (Hospital Universitario Miguel Servet (Saragossa)) ;
Gronchi, Alessandro (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Haro-Varas, Juan (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Hindi, Nadia (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
Huanca, Lourdes (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ;
Jimenez, Natalia (Hospital San Vicente de Paúl (Heredia)) ;
Karanian, Marie (Léon Bérard Center (Lyon)) ;
Kasper, Bernd (University of Heidelberg (Mannheim)) ;
Lopes, Artur (A.C.Camargo Cancer Center (Brasil)) ;
Lopes David, B.B. (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Lutter, Guido (Instituto Alexander Fleming (Buenos Aires)) ;
Maki, Robert G. (University of Pennsylvania (New York)) ;
Martinez-Said, Héctor (Hospital Medica Sur (Mexico)) ;
Martinez-Tlahuel, Jorge Luis (Instituto Nacional de Cancerología (Tlalpan)) ;
Mello, Celso A. (A.C.Camargo Cancer Center (Brasil)) ;
Morales Pérez, José Manuel (Hospital Medica Sur (Mexico)) ;
Moura, David S. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Nakagawa, Suely Akiko (A.C.Camargo Cancer Center (Brasil)) ;
Nascimento, Antônio Geraldo (A.C.Camargo Cancer Center (Brasil)) ;
Ortiz-Cruz, Eduardo J. (Hospital Universitario La Paz (Madrid)) ;
Patel, Shreyaskumar (University of Texas MD Anderson Cancer Center (Houston)) ;
Pfluger, Yanina (Instituto Alexander Fleming (Buenos Aires)) ;
Provenzano, Salvatore (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Righi, Alberto (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
Rodriguez, Andrés (Instituto Alexander Fleming (Buenos Aires)) ;
Santos, Telma G. (A.C.Camargo Cancer Center (Brasil)) ;
Scotlandi, Katia (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ;
MLG, Silva (A.C.Camargo Cancer Center (Brasil)) ;
Soulé, Tomás (Instituto Alexander Fleming (Buenos Aires)) ;
Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ;
Valverde, Claudia María (Hospital Universitari Vall d'Hebron) ;
Waisberg, Federico Daniel (Instituto Alexander Fleming (Buenos Aires)) ;
Zamora Estrada, Esteban (Hospital Dr. R. A. Calderón Guardia (San José)) ;
Martín-Broto, Javier (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)
Bone sarcoma are infrequent diseases, representing < 0. 2% of all adult neoplasms. A multidisciplinary management within reference centers for sarcoma, with discussion of the diagnostic and therapeutic strategies within an expert multidisciplinary tumour board, is essential for these patients, given its heterogeneity and low frequency. [...]
2022 - 10.1016/j.critrevonc.2022.103685
Critical Reviews in Oncology/Hematology, Vol. 174 (june 2022) , p. 103685
|
|
|
8.
|
|
15 p, 942.2 KB |
A growth modulation index-based geistra score as a new prognostic tool for trabectedin efficacy in patients with advanced soft tissue sarcomas : A Spanish group for sarcoma research (GEIS) retrospective study
/
Martínez-Trufero, Javier (Hospital Universitario Miguel Servet (Saragossa)) ;
Sande-González, Luis Miguel de (Hospital Universitario de León) ;
Luna, Pablo (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Martín-Broto, Javier (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Alvarez, Rosa (Hospital General Universitario Gregorio Marañón) ;
Marquina, Gloria (Hospital Universitario Clínico San Carlos (Madrid)) ;
Diaz-Beveridge, Roberto (Hospital Universitari i Politècnic La Fe (València)) ;
Poveda, Andrés (Instituto Valenciano de Oncologia) ;
Cano, Juana María (Hospital General de Ciudad Real) ;
Cruz-Jurado, Josefina (Hospital Universitario Canarias) ;
López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Salgado, María Angeles Vaz (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ;
Valverde-Morales, Claudia Maria. (Hospital Universitari Vall d'Hebron) ;
Sevilla, Isabel (Universitarios Regional y Virgen de la Victoria de Málaga) ;
Martínez-García, Jerónimo (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ;
Rubio-Casadevall, Jordi (Institut Català d'Oncologia) ;
de Juan Ferre, Ana (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Carrasco, Juan Antonio (Hospital Álvaro Cunqueiro (Vigo)) ;
Moura, David S. (Instituto de Biomedicina de Sevilla) ;
Gurruchaga-Sotes, Ibon (Hospital Universitario Miguel Servet (Saragossa)) ;
Gutiérrez, Antonio (Hospital Universitari Son Espases (Palma de Mallorca, Balears))
The aim of this study was to identify an easily reliable prognostic score that selects the subset of advanced soft tissue sarcoma (ASTS) patients with a higher benefit with trabectedin in terms of time to progression and overall survival. [...]
2021 - 10.3390/cancers13040792
Cancers, Vol. 13 Núm. 4 (february 2021) , p. 1-15
|
|
|
9.
|
|
9 p, 838.3 KB |
SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)
/
de Juan Ferré, Ana (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Alvarez, Rosa (Hospital General Universitario Gregorio Marañón) ;
Casado Herráez, Antonio (Hospital Universitario Clínico San Carlos (Madrid)) ;
Cruz-Jurado, Josefina (Hospital Universitario de Canarias (La Laguna)) ;
Estival, Anna (Institut Català d'Oncologia) ;
Martín-Broto, Javier (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Martínez Marín, Virginia (Hospital Universitario La Paz (Madrid)) ;
Moreno Vega, Alberto Luis (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Sebio, Ana (Institut d'Investigació Biomèdica Sant Pau) ;
Valverde Morales, Claudia (Hospital Universitari Vall d'Hebron)
Soft-tissue sarcomas constitute an uncommon and heterogeneous group of tumors of mesenchymal origin. Diagnosis, treatment, and management should be performed by an expert multidisciplinary team. MRI/CT of the primary tumor and biopsy is mandatory before any treatment. [...]
2021 - 10.1007/s12094-020-02534-0
Clinical & Translational Oncology, Vol. 23 Núm. 5 (may 2021) , p. 922-930
|
|
|
10.
|
|
14 p, 2.6 MB |
Epithelioid hemangioendothelioma, an ultra-rare cancer : a consensus paper from the community of experts
/
Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Miah, Aisha B. (The Royal Marsden Hospital) ;
Frezza, Anna Maria (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Messiou, Christina (Department of Radiology. The Royal Marsden Hospital and The Institute of Cancer Research) ;
Morosi, Carlo (Radiology Department. Fondazione IRCCS Istituto Nazionale Tumori) ;
Caraceni, Augusto (Fondazione IRCCS Istituto Nazionale Tumori) ;
Antonescu, Cristina (Memorial Sloan Kettering Cancer Center) ;
Bajpai, Jyoti (Homi Bhabha National Institute. Medical Oncology Department) ;
Baldini, Elizabeth Healey (Dana-Farber Cancer Center/Brigham) ;
Bauer, Sebastian (University of Duisburg-Essen) ;
Biagini, Roberto (Regina Elena National Cancer Institute) ;
Bielack, Stefan S. (Klinikum Stuttgart - Olgahospital) ;
Blay, Jean-Yves (Department of Medical Oncology. Centre Leon Berard. Université Claude Bernard Lyon. Unicancer) ;
Bonvalot, Sylvie (Institut Curie. Department of Surgical Oncology) ;
Boukovinas, Ioannis P. (Nordix) ;
Bovee, Judith V.M.G. (Leiden University Medical Center) ;
Boye, Kjetil (The Norwegian Radium Hospital) ;
Brodowicz, Thomas (Medical University Vienna) ;
Callegaro, Dario (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
De Álava, Enrique (Department of Normal and Pathological Cytology and Histology. School of Medicine. University of Seville) ;
Deoras-Sutliff, M. (The EHE Foundation) ;
Dufresne, Armelle (Department of Medical Oncology. Centre Leon Berard. Université Claude Bernard Lyon. Unicancer) ;
Eriksson, Mikael (Department of Oncology. Skane University Hospital and Lund University) ;
Errani, Costantino (Orthopaedic Service. Musculoskeletal Oncology Department. IRCCS Istituto Ortopedico Rizzoli) ;
Fedenko, Alexander (Medical Oncology Division. P.A. Herzen Cancer Research Institute) ;
Ferraresi, Virginia (Sarcomas and Rare Tumors Unit. IRCCS Regina Elena National Cancer Institute) ;
Ferrari, Andrea (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Fletcher, Christopher D.M. (Department of Pathology Brigham & Women's Hospital) ;
Garcia del Muro, Xavier (Universitat de Barcelona) ;
Gelderblom, Hans J. (Department of Medical Oncology. Leiden University Medical Center) ;
Gladdy, Rebecca A. (University of Toronto and Lunenfeld-Tanenbaum Research Institute) ;
Gouin, François (Department of Surgery. Centre Leon Berard) ;
Grignani, Giovanni (Candiolo Cancer Institute. FPO - IRCCS) ;
Gutkovich, J. (NUY Langone Medical Center) ;
Haas, Rick (Department of Radiotherapy. the Leiden University Medical Center) ;
Hindi, Nadia (Universidad de Sevilla. Instituto de Biomedicina de Sevilla) ;
Hohenberger, Peter (Mannheim University Medical Center) ;
Huang, Paul (Division of Molecular Pathology. The Institute of Cancer Research) ;
Joensuu, Heikki T. (Department of Oncology. Helsinki University Hospital & Helsinki University) ;
Jones, Robin Lewis (Department of Cancer. The Royal Marsden Hospital and The Institute of Cancer Research) ;
Jungels, Christiane (Institut Jules Bordet. Université Libre de Bruxelles) ;
Kasper, Bernd (University of Heidelberg. Mannheim University Medical Center. Sarcoma Unit) ;
Kawai, Akira (Musculoskeletal Oncology and Rehabilitation Medicine. Rare Cancer Center National Cancer Center Hospital) ;
Le Cesne, Axel (International Department. Gustave Roussy) ;
Le Grange, Franél (UCLH - University College London Hospitals NHS Foundation Trust) ;
Leithner, Andeas (Department of Orthopaedics and Trauma Medical University Graz) ;
Leonard, H. (Chair of Trustees of the EHE Rare Cancer Charity (UK). Charity number 1162472) ;
López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Martin Broto, Javier (Hospital Universitario Fundación Jiménez Díaz) ;
Merimsky, Ofer (Unit of Soft Tissue and Bone Oncology. Division of Oncology. Tel-Aviv Medical Center affiliated with Sackler School of Medicine. Tel Aviv University) ;
Merriam, Priscilla (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Department of Medical Oncology) ;
Miceli, Rosalba (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Mir, Olivier (Sarcoma Group. Gustave Roussy) ;
Molinari, Massimo (University of Pittsburgh Medical Center. Thomas Starzl Transplant Institute) ;
Montemurro, Michael (Oncology. CHUV Lausanne) ;
Oldani, Graziano (Division of Abdominal Surgery. University Hospitals of Geneva) ;
Palmerini, Emanuela (Chemotherapy Unit. IRCCS Istituto Ortopedico Rizzoli) ;
Pantaleo, Maria Abbondanza. (Division of Oncology. IRCCS Azienda Ospedaliero-Universitaria di Bologna) ;
Patel, Sapna Pradyuman (Sarcoma Center. The University of Texas M.D. Anderson Cancer Center) ;
Piperno-Neumann, Sophie (Department of Medical Oncology. Institut Curie) ;
Raut, Chandrajit Premanand (Dana Farber Cancer Center. Harvard Medical School) ;
Ravi, Vinod (Sarcoma Center. The University of Texas M.D. Anderson Cancer Center) ;
Razak, Albiruni Ryan Abdul (Princess Margaret Cancer Centre and Sinai Healthcare System & Faculty of Medicine. University of Toronto) ;
Reichardt, Peter (Helios Klinikum Berlin-Buch. Department of Oncology and Palliative Care) ;
Rubin, Brian P. (Robert J. Tomsich Pathology and Laboratory Medicine Institute. Cleveland Clinic) ;
Rutkowski, Piotr (Maria Sklodowska-Curie National Research Institute of Oncology. Department of Soft Tissue/Bone Sarcoma and Melanoma) ;
Safwat, Akmal Ahmed (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Sangalli, Claudia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Sapisochin, Gonzalo (Multi-Organ Transplant and HPB Surgical Oncology. Division of General Surgery. Department of Surgery. University of Toronto) ;
Sbaraglia, Marta (Department of Pathology. Azienda Ospedaliera Università Padova) ;
Scheipl, Susanne (Department of Orthopaedics and Trauma. Medical University of Graz) ;
Schöffski, Patrick (Leuven Cancer Institute) ;
Strauss, Dirk Cornelius (Department of Surgery. The Royal Marsden Hospital and The Institute of Cancer Research) ;
Strauss, Sandra J. (University College London Hospital) ;
Sundby Hall, Kirsten (Department of Oncology. Oslo University Hospital. The Norwegian Radium Hospital) ;
Tap, William D. (Department of Medicine. Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College) ;
Trama, Annalisa (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Tweddle, A. (Palliative Care. The Royal Marsden Hospital and The Institute of Cancer Research London) ;
van der Graaf, Winette T.A. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
van de Sande, Michiel (Department of Orthopedic Surgery Bone and Soft Tissue Tumor Unit. Leiden University Medical Center) ;
Van Houdt, Winan (Sarcoma and Melanoma Unit. The Netherlands Cancer Institute) ;
van Oortmerssen, Gerard (Co-Chair of Sarcoma Patients EuroNet (SPAEN). Woelfersheim. Germany & Chairman of the Dutch organisation for sarcoma patients (Patiëntenplatform Sarcomen). Guest researcher at Leiden University (Leiden Institute for Advanced Computer Science). Leiden University) ;
Wagner, Andrew J. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Department of Medical Oncology) ;
Wartenberg, Markus (Chair of the Board of Directors of Sarcoma Patients EuroNet (SPAEN). Sarcoma Patients EuroNet (SPAEN)) ;
Wood, J. (The Royal Marsden NHS Foundation Trust) ;
Zaffaroni, Nadia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Zimmermann, Camilla (Department of Supportive Care. Princess Margaret Cancer Centre and Division of Palliative Medicine. Department of Medicine. University of Toronto) ;
Casali, Paolo Giovanni (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Dei Tos, Angelo (Department of Pathology. Azienda Ospedaliera Università Padova) ;
Gronchi, Alessandro (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia))
Epithelioid hemangioendothelioma (EHE) is an ultra-rare, translocated, vascular sarcoma. EHE clinical behavior is variable, ranging from that of a low-grade malignancy to that of a high-grade sarcoma and it is marked by a high propensity for systemic involvement. [...]
2021 - 10.1016/j.esmoop.2021.100170
ESMO open, Vol. 6 Núm. 3 (june 2021) , p. 100170
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
